These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24565445)

  • 21. Cardiac microphysiological devices with flexible thin-film sensors for higher-throughput drug screening.
    Lind JU; Yadid M; Perkins I; O'Connor BB; Eweje F; Chantre CO; Hemphill MA; Yuan H; Campbell PH; Vlassak JJ; Parker KK
    Lab Chip; 2017 Oct; 17(21):3692-3703. PubMed ID: 28976521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle.
    Xiao Y; Zhang B; Liu H; Miklas JW; Gagliardi M; Pahnke A; Thavandiran N; Sun Y; Simmons C; Keller G; Radisic M
    Lab Chip; 2014 Mar; 14(5):869-82. PubMed ID: 24352498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Cardiotoxicity With Stem Cell-based Strategies.
    Stella Stoter AM; Hirt MN; Stenzig J; Weinberger F
    Clin Ther; 2020 Oct; 42(10):1892-1910. PubMed ID: 32938533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical approaches to assess potential kinase inhibitor-induced cardiac toxicity: Past, present and future.
    Yang B; Papoian T
    J Appl Toxicol; 2018 Jun; 38(6):790-800. PubMed ID: 29369373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications.
    Phan DTT; Wang X; Craver BM; Sobrino A; Zhao D; Chen JC; Lee LYN; George SC; Lee AP; Hughes CCW
    Lab Chip; 2017 Jan; 17(3):511-520. PubMed ID: 28092382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system.
    Kolanowski TJ; Busek M; Schubert M; Dmitrieva A; Binnewerg B; Pöche J; Fisher K; Schmieder F; Grünzner S; Hansen S; Richter A; El-Armouche A; Sonntag F; Guan K
    Acta Biomater; 2020 Jan; 102():273-286. PubMed ID: 31778832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures.
    Sacchetto C; Vitiello L; de Windt LJ; Rampazzo A; Calore M
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cell derived in vivo-like human cardiac bodies in a microfluidic device for toxicity testing by beating frequency imaging.
    Bergström G; Christoffersson J; Schwanke K; Zweigerdt R; Mandenius CF
    Lab Chip; 2015 Aug; 15(15):3242-9. PubMed ID: 26135270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Microfluidic Bioreactor for Toxicity Testing of Stem Cell Derived 3D Cardiac Bodies.
    Christoffersson J; Bergström G; Schwanke K; Kempf H; Zweigerdt R; Mandenius CF
    Methods Mol Biol; 2016; 1502():159-68. PubMed ID: 27052611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient Protocols for Fabricating a Large Human Cardiac Muscle Patch from Human Induced Pluripotent Stem Cells.
    Gao L; Zhang JJ
    Methods Mol Biol; 2021; 2158():187-197. PubMed ID: 32857374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.
    Sallam K; Li Y; Sager PT; Houser SR; Wu JC
    Circ Res; 2015 Jun; 116(12):1989-2004. PubMed ID: 26044252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device.
    van der Meer AD; Orlova VV; ten Dijke P; van den Berg A; Mummery CL
    Lab Chip; 2013 Sep; 13(18):3562-8. PubMed ID: 23702711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innovations in preclinical biology: ex vivo engineering of a human kidney tissue microperfusion system.
    Kelly EJ; Wang Z; Voellinger JL; Yeung CK; Shen DD; Thummel KE; Zheng Y; Ligresti G; Eaton DL; Muczynski KA; Duffield JS; Neumann T; Tourovskaia A; Fauver M; Kramer G; Asp E; Himmelfarb J
    Stem Cell Res Ther; 2013; 4 Suppl 1(Suppl 1):S17. PubMed ID: 24564863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells.
    Takeda M; Miyagawa S; Fukushima S; Saito A; Ito E; Harada A; Matsuura R; Iseoka H; Sougawa N; Mochizuki-Oda N; Matsusaki M; Akashi M; Sawa Y
    Tissue Eng Part C Methods; 2018 Jan; 24(1):56-67. PubMed ID: 28967302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aligned nanofiber scaffolds improve functionality of cardiomyocytes differentiated from human induced pluripotent stem cell-derived cardiac progenitor cells.
    Ding M; Andersson H; Martinsson S; Sabirsh A; Jonebring A; Wang QD; Plowright AT; Drowley L
    Sci Rep; 2020 Aug; 10(1):13575. PubMed ID: 32782331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Future of Direct Cardiac Reprogramming: Any
    López-Muneta L; Miranda-Arrubla J; Carvajal-Vergara X
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines.
    Martinez-Fernandez A; Li X; Hartjes KA; Terzic A; Nelson TJ
    Circ Cardiovasc Genet; 2013 Oct; 6(5):462-71. PubMed ID: 24036272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multi-parameter in vitro screen in human stem cell-derived cardiomyocytes identifies ponatinib-induced structural and functional cardiac toxicity.
    Talbert DR; Doherty KR; Trusk PB; Moran DM; Shell SA; Bacus S
    Toxicol Sci; 2015 Jan; 143(1):147-55. PubMed ID: 25304212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types.
    Doherty KR; Talbert DR; Trusk PB; Moran DM; Shell SA; Bacus S
    Toxicol Appl Pharmacol; 2015 May; 285(1):51-60. PubMed ID: 25841593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human mesenchymal stem cell (hMSC) differentiation towards cardiac cells using a new microbioanalytical method.
    Sokolowska P; Zukowski K; Lasocka I; Szulc-Dabrowska L; Jastrzebska E
    Analyst; 2020 Apr; 145(8):3017-3028. PubMed ID: 32133460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.